L-asparaginase. Perspectives on the mechanisms of action and resistance

International Journal of Pediatric Hematology/Oncology

Volumn 4, Issue 6, 1997, Pages 597-611

  Chakrabarti, R ^a   Schuster, S M ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

Asparagine; Asparagine synthetase; Chemical modification; L asparaginase; Resistance

Indexed keywords

ANTILEUKEMIC AGENT; ANTINEOPLASTIC AGENT; ASPARAGINASE; ASPARAGINE; ASPARTATE AMMONIA LIGASE; DOXORUBICIN; PLASMA PROTEIN; PREDNISONE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; AMINO ACID SYNTHESIS; BLEEDING; BLOOD CLOTTING DISORDER; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CHEMICAL MODIFICATION; CHILDHOOD LEUKEMIA; DRUG BLOOD LEVEL; DRUG CONJUGATION; DRUG HALF LIFE; DRUG HYPERSENSITIVITY; DRUG MECHANISM; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME INACTIVATION; FACE EDEMA; HEMORRHAGIC PANCREATITIS; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; HYPOTENSION; LARYNX SPASM; MUSCLE WEAKNESS; PRIORITY JOURNAL; PROTEIN DEFICIENCY; RESPIRATORY DISTRESS; REVIEW; SEIZURE; STRUCTURE ACTIVITY RELATION;

EID: 0031408593     PISSN: 10702903     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (114)